Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Evans

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
Nuklearmedizin. Nuclear Medicine|March 18, 2025
Intratumoral distribution and pharmacokinetics of the radiolabeled ICAM-1 targeting monoclonal antibody R6.5 in a prostate cancer mouse modelAnders Örbom, Susan Evans-Axelsson, Bo Jansson, et al.
Annals of Surgical Oncology|May 11, 2013
Are breast cancer subtypes prognostic for nodal involvement and associated with clinicopathologic features at presentation in early-stage breast cancer?Tiffanie Jones, Hanmanth Neboori, H Wu, et al.
Clinical Chemistry|September 18, 2015
Triangulating Dynamic of Clinical Laboratory TestingKerri Weinert, Peter Gyorda, Nader Rifai, et al.
British Journal of Pharmacology|February 13, 2025
An optimised Bcl-3 inhibitor for melanoma treatmentKarunakar Saamarthy, Renée Daams, Wondossen Sime, et al.
EJNMMI Research|June 28, 2015
Preclinical imaging of kallikrein-related peptidase 2 (hK2) in prostate cancer with a (111)In-radiolabelled monoclonal antibody, 11B6Oskar Vilhelmsson Timmermand, David Ulmert, Susan Evans-Axelsson, et al.
European Journal of Cancer Care|December 28, 2020
Measuring psychosocial outcomes of men living with prostate cancer: feasibility of regular assessment of patient-reported outcomesKerry Ettridge, Kathleen Wright, David Smith, et al.
American Journal of Nuclear Medicine and Molecular Imaging|July 2, 2014
Preclinical evaluation of (111)In-DTPA-INCA-X anti-Ku70/Ku80 monoclonal antibody in prostate cancerSusan Evans-Axelsson, Oskar Vilhelmsson Timmermand, Charlotte Welinder, et al.
Trauma Surgery & Acute Care Open|November 7, 2025
Surgeon leadership in trauma resuscitation requires a competency-based multimodal training frameworkGary Alan Bass, Caoimhe C Duffy, Jeremy W Cannon, et al.
BMC Health Services Research|January 19, 2020
Development of a percutaneous coronary intervention patient level composite measure for a clinical quality registryDarshini Ayton, Sze-Ee Soh, Renata Morello, et al.
BJU International|January 25, 2022
Large variation in conservative management of low-risk prostate cancer in Australia and New ZealandWee Loon Ong, Isaac Thangasamy, Declan Murphy, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Nuklearmedizin. Nuclear Medicine|March 18, 2025
Intratumoral distribution and pharmacokinetics of the radiolabeled ICAM-1 targeting monoclonal antibody R6.5 in a prostate cancer mouse modelAnders Örbom, Susan Evans-Axelsson, Bo Jansson, et al.
Annals of Surgical Oncology|May 11, 2013
Are breast cancer subtypes prognostic for nodal involvement and associated with clinicopathologic features at presentation in early-stage breast cancer?Tiffanie Jones, Hanmanth Neboori, H Wu, et al.
Clinical Chemistry|September 18, 2015
Triangulating Dynamic of Clinical Laboratory TestingKerri Weinert, Peter Gyorda, Nader Rifai, et al.
British Journal of Pharmacology|February 13, 2025
An optimised Bcl-3 inhibitor for melanoma treatmentKarunakar Saamarthy, Renée Daams, Wondossen Sime, et al.
EJNMMI Research|June 28, 2015
Preclinical imaging of kallikrein-related peptidase 2 (hK2) in prostate cancer with a (111)In-radiolabelled monoclonal antibody, 11B6Oskar Vilhelmsson Timmermand, David Ulmert, Susan Evans-Axelsson, et al.
European Journal of Cancer Care|December 28, 2020
Measuring psychosocial outcomes of men living with prostate cancer: feasibility of regular assessment of patient-reported outcomesKerry Ettridge, Kathleen Wright, David Smith, et al.
American Journal of Nuclear Medicine and Molecular Imaging|July 2, 2014
Preclinical evaluation of (111)In-DTPA-INCA-X anti-Ku70/Ku80 monoclonal antibody in prostate cancerSusan Evans-Axelsson, Oskar Vilhelmsson Timmermand, Charlotte Welinder, et al.
Trauma Surgery & Acute Care Open|November 7, 2025
Surgeon leadership in trauma resuscitation requires a competency-based multimodal training frameworkGary Alan Bass, Caoimhe C Duffy, Jeremy W Cannon, et al.
BMC Health Services Research|January 19, 2020
Development of a percutaneous coronary intervention patient level composite measure for a clinical quality registryDarshini Ayton, Sze-Ee Soh, Renata Morello, et al.
BJU International|January 25, 2022
Large variation in conservative management of low-risk prostate cancer in Australia and New ZealandWee Loon Ong, Isaac Thangasamy, Declan Murphy, et al.
Pageof 10